Know How Nexletol Stacks Up to Other Non-Statins

April 2020

You’ll hear buzz about Nexletol (NEKS-leh-tol, bempedoic acid), a new oral non-statin cholesterol med.

Nexletol is the first ATP-citrate lyase inhibitor...blocking an earlier step of cholesterol synthesis in the liver than statins.

It’s approved for patients with familial hypercholesterolemia or CV disease who need more LDL lowering...despite max tolerated statins.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: PA includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote